Subscribe to Newsletter


Subspecialties Retina

Weighing the Cost

| Jed Boye | 4 min read

Is Ozempic’s higher rates of diabetic retinopathy and adverse ocular events compared to other GLP-1 agonists cause for concern?

Subspecialties Retina

Off-Label, On Point

| Blake Cooper | 10 min read

Why I support the off-label use of semaglutide for many indications – including weight loss

Subspecialties Retina

Deep Cuts… and Other News

| Jed Boye | 3 min read

We share some of the most interesting recent Retina research

Subspecialties Retina

Electrifying RP Treatment

| Sarah Healey | 5 min read

Is OkuStim the future of retinitis pigmentosa treatment?

Subspecialties Retina

Stopping The Unstoppable

| Sarah Healey | 6 min read

FDA approve new treatment for geographic atrophy

Subspecialties Cataract

ARED QOL… and Other News

| Jed Boye | 3 min read

We explore the most interesting anterior segment research

Subspecialties Basic & Translational Research

A Translation Boost for USH

| Sarah Healey | 4 min read

Improving translational models for inherited retinal diseases

Subspecialties Retina

Real ROP Progress

| Sarah Healey | 3 min read

EYLEA: The FDA approved VEGF inhibitor for ROP

Subspecialties Imaging & Diagnostics

Seeing The Difference

| Sponsored by Topcon Healthcare | 4 min read

Two ophthalmologists share how Topcon’s Triton OCT makes a difference in their clinics.

Subspecialties Imaging & Diagnostics

Crystal Clear Capsulotomy

| Jon Greenaway

Our image of the month, from the Ophthalmic Photographers Society

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: